Research Expert: Sarah Overall
  • Published: Feb 2025
  • Pages: 150
  • SKU: IRTNTR70605

  • Latest News- Type 2 Diabetes Market: Insulin is expected to lead the Drug Class segment during 2025-2029

    The Type 2 Diabetes Market is being driven by Rising prevalence of diabetes

    The Type 2 Diabetes Market is expected to grow at a CAGR of 12.2% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 53.8 billion. The aging population represents a significant economic burden on healthcare systems due to increasing healthcare expenditures. With population aging being a global trend, the prevalence of diabetes is anticipated to surge in both developed and developing countries. Older adults are disproportionately affected by Type 2 diabetes, primarily due to age-related insulin resistance and impaired pancreatic islet function. Age-related factors, including adiposity, sarcopenia, and physical inactivity, contribute to insulin resistance. Moreover, the beta cells of the pancreas exhibit decreased proliferative capacity and accelerated apoptosis as individuals age, exacerbating the development of Type 2 diabetes. 

    Get more information on Type 2 Diabetes Market by requesting a sample report

    Which Factors Are Causing a Surge in Market Growth?

    The market is segmented based on segments_for_ai.nslist

    According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

    • Rising prevalence of diabetes
    • Rise in prevalence of obesity and changing lifestyles
    • Recent product approvals

    However, the market also witnesses some limitations, which are as follows:

    • Low diagnosis rate
    • Rising concerns among scientific community
    • Gaps in national-level diabetes management programs

    Benefits of Buying Global Type 2 Diabetes Market Research Report by Technavio

    Rich Experience: 20+ years leading global market research, trusted insights across industries.

    Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

    Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

    Market Scope in Type 2 Diabetes Market Research Report

    Market Scope

    Report Coverage

    Details

    Page number

    221

    Base year

    2024

    Historic period

    2019-2023

    Forecast period

    2025-2029

    Growth momentum & CAGR

    Accelerate at a CAGR of 12.2%

    Market growth 2025-2029

    USD 53.8 billion

    Market structure

    Fragmented

    YoY growth 2024-2025(%)

    10.5

    Key countries

    US, Germany, Canada, China, UK, India, France, Japan, Italy, and South Korea

    Competitive landscape

    Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

    Request Free Sample

    Find out which segment is leading the market by accessing the free PDF report

    Research Analysis Overview

    The Type 2 Diabetes market caters to adolescents and young adults, providing therapeutic compounds to manage complications such as cardiovascular diseases, renal problems, and neurological issues. Insulin and non-insulin medications like Jardiance, Tanzeum, and Trulicity help maintain normal blood glucose levels, alleviating symptoms such as increased thirst, urination, fatigue, blurred vision, slow-healing wounds, infections, tingling, and numbness in feet and hands. Pharmaceutical companies offer these treatments through retail pharmacies to combat hyperglycemia's effects on the heart, kidneys, eyes, blood vessels, and nerves.

    Market Research Overview

    The Type 2 Diabetes market is a significant segment of the global pharmaceuticals industry, encompassing entities involved in the research and development or manufacturing of therapeutic compounds for adolescents, teenagers, and young adults. Factors driving market growth include the rising prevalence of cardiovascular diseases, renal problems, and neurological complications associated with Type 2 Diabetes. Key therapeutic classes include insulin, thiazolidinediones, which act on PPAR receptors, and adiponectin-based treatments. Retail pharmacies and online platforms are essential distribution channels. The market's expansion is influenced by demographic trends, such as the aging population, with Europe and North America predicted to have a substantial proportion of citizens aged 60 years and above by 2030 and 2050, respectively.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.


    Contacts

    Technavio Research
    Jesse Maida
    Media & Marketing Executive
    US: +1 844 364 1100
    UK: +44 203 893 3200
    Email: media@technavio.com
    Website: www.technavio.com/

    Read News Read Less
    Interested in this report?
    Get your sample now!

Safe and Secure SSL Encrypted

Technavio

  • 2500 USD

[5 reports/month/user]

  • 5000 USD

close
  • Basic Plan [5000 USD/Year]:

    Single User
    Download 5 Reports/Month
    View 100 Reports/Month
    Add upto 3 Users at 625 USD/user

  • Teams Plan [7500 USD/Year]:

    5 User
    Download 5 Reports/Month/User
    View 100 Reports/Month/User
    Add upto 30 Users at 500 USD/user

*You can upgrade to Teams plan at Subscription page

close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization).
    Complimentary Customization Included

*For Enterprise license, go to checkout page

Technavio Get the report (PDF) sent to your email within minutes.